These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17917510)

  • 21. [Comparative trial of combined oxprenolol-chlorthalidone and a beta-blockader and diuretic separately in primary arterial hypertension].
    Luna RL; Faerchtein I; de Vasconcelos EM; Arslanian L; de La Nuez SB; Pereira WQ; Puppin S; Campos JC; Roque AF; Kastansky I
    Arq Bras Cardiol; 1979 Oct; 33(4):311-20. PubMed ID: 398212
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of diuretic, beta-adrenoceptor blocking agent and their combination on elevated blood pressure and serum potassium: a cross-over study.
    Neuvonen PJ; Pentikäinen PJ; Jounela AJ
    Br J Clin Pharmacol; 1978 Oct; 6(4):363-7. PubMed ID: 29653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.
    Václavík J; Sedlák R; Plachy M; Navrátil K; Plásek J; Jarkovsky J; Václavík T; Husár R; Kociánová E; Táborsky M
    Hypertension; 2011 Jun; 57(6):1069-75. PubMed ID: 21536989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist.
    Johnston LC; Grieble HG
    Arch Intern Med; 1967 Mar; 119(3):225-31. PubMed ID: 6020067
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension.
    Vaclavik J; Sedlak R; Jarkovsky J; Kocianova E; Taborsky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Mar; 157(1):50-5. PubMed ID: 23128822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of arterial hypertension with diuretics].
    Fritel D; Fendler JP
    Sem Ther; 1967; 43(6):381-4. PubMed ID: 5618021
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the antihypertensive activities of xipamide and chlorthalidone: a double-blind, randomized, crossover trial.
    Bonaduce D; Ferrara N; Petretta M; Canonico V; Romango E; Rengo F
    Curr Med Res Opin; 1981; 7(4):247-52. PubMed ID: 7014105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
    Khosla N; Chua DY; Elliott WJ; Bakris GL
    J Clin Hypertens (Greenwich); 2005 Jun; 7(6):354-6. PubMed ID: 16088299
    [No Abstract]   [Full Text] [Related]  

  • 29. Chlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease?
    Pitt B; Auchus RJ
    Hypertension; 2024 Jan; 81(1):107-109. PubMed ID: 37909173
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.
    Hwang AY; Dave C; Smith SM
    Hypertension; 2016 Dec; 68(6):1349-1354. PubMed ID: 27777360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in urinary electrolytes versus serum electrolytes during treatment of primary hypertension with chlorthalidone alone and in combination with spironolactone.
    Falch DK; Schreiner AM
    Acta Med Scand; 1981; 209(1-2):111-4. PubMed ID: 7010926
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiovascular response to isometric exercise test during beta blocker and diuretic treatment in essential arterial hypertension].
    Maiorano G; Contursi V; Saracino E; Ricapito M; Di Lecce G
    Clin Ter; 1988 Mar; 124(6):443-50. PubMed ID: 2904846
    [No Abstract]   [Full Text] [Related]  

  • 33. Do thiazide diuretics reduce central systolic blood pressure in hypertension?
    Yugar LBT; Moreno B; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):133-135. PubMed ID: 29106774
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M; Mifune M; Kubota E; Itoh H; Saito I
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant hypertension optimal treatment trial: a randomized controlled trial.
    ; Krieger EM; Drager LF; Giorgi DM; Krieger JE; Pereira AC; Barreto-Filho JA; da Rocha Nogueira A; Mill JG
    Clin Cardiol; 2014 Jan; 37(1):1-6. PubMed ID: 24338935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension.
    Drayer JI; Kloppenborg PW; Festen J; van't Laar A; Benraad TJ
    Am J Cardiol; 1975 Oct; 36(5):716-21. PubMed ID: 1103606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension].
    Widimský J
    Vnitr Lek; 2015 Dec; 61(12):1067-71. PubMed ID: 26806502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.